Literature DB >> 30850098

Risk Factors Associated With Major Lower Extremity Amputation After Osseous Diabetic Charcot Reconstruction.

Tammer Elmarsafi1, Ersilia L Anghel1, Jeremy Sinkin2, Paul S Cooper3, John S Steinberg2, Karen K Evans2, Paul J Kim2, Christopher E Attinger4.   

Abstract

Patients with diabetic Charcot neuroarthropathy (CN) are at high risk for ulcerations and major lower extremity amputations (LEAs). Osseous reconstruction is an important component in ulcer healing and prevention; however, despite such efforts, major LEAs remain a serious postreconstruction concern. The aim of this study was to identify risk factors for major LEA in patients who underwent osseous Charcot reconstruction. A retrospective review was performed on 331 patients with the diagnosis of CN in the foot and ankle treated over a 16-year period. Two hundred eighty-five patients were included after exclusion of those without diabetes. Demographic data, anatomic wound location, surgical interventions, wound healing status, and the level of eventual amputation were recorded. Multivariate logistic regression and Fisher's exact test were used for analysis. All patients had diabetes, neuropathy, or CN and required osseous reconstruction. Risk factors and their respective odds ratios (ORs) are as follows: postoperative nonunion (OR 8.5, 95% confidence interval [CI] 2.2 to 33.5, 0.0023), development of new site of CN (OR 8.2; 95% CI 1.1 to 62.9; p = .0440), peripheral arterial disease (OR 4.3; 95% CI 1.7 to 11.0; p = .0020), renal disease (OR 3.7; 95% CI 1.6 to 8.8; p = .0025), postoperative delayed healing (OR 2.6; 95% CI 1.1 to 6.5; p = .0371), postoperative osteomyelitis (OR 2.4; 95% CI 1.0 to 5.9; p = .0473), or elevated glycated hemoglobin (OR 1.2; 95% CI 1.0 to 1.4; p = .0053). Independent risk factors found to be statistically significant for major LEA in diabetic CN in the setting of osseous reconstruction must be mitigated for long-term prevention of major amputations.
Copyright © 2018 the American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Charcot neuroarthropathy; diabetes; major amputation; neuropathy; nonunion; peripheral arterial disease; reconstruction; ulcer

Mesh:

Year:  2019        PMID: 30850098     DOI: 10.1053/j.jfas.2018.08.059

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  4 in total

1.  Charcot foot reconstruction outcomes: A systematic review.

Authors:  Joon Ha; Thomas Hester; Robert Foley; Ines L H Reichert; Prashanth R J Vas; Raju Ahluwalia; Venu Kavarthapu
Journal:  J Clin Orthop Trauma       Date:  2020-04-20

2.  Effect and Mechanism of the Bruton Tyrosine Kinase (Btk) Inhibitor Ibrutinib on Rat Model of Diabetic Foot Ulcers.

Authors:  Xuedong Yang; Zhenhao Cao; Peigang Wu; Zhong Li
Journal:  Med Sci Monit       Date:  2019-10-23

Review 3.  Development and use of the PodEssential and Paeds-PodEssential triage tools to define "essential" podiatry services. A Delphi survey, scoping review, and face validity testing study.

Authors:  Cylie M Williams; Alicia James; Sindhrani Dars; Helen Banwell
Journal:  J Foot Ankle Res       Date:  2022-03-08       Impact factor: 2.303

4.  Long-term follow-up of conservative treatment of Charcot feet.

Authors:  Viviane Gratwohl; Thorsten Jentzsch; Madlaina Schöni; Dominik Kaiser; Martin C Berli; Thomas Böni; Felix W A Waibel
Journal:  Arch Orthop Trauma Surg       Date:  2021-04-07       Impact factor: 2.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.